EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 5 July 2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.

Read more

Videos

A lifetime of breakthroughs
We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades... Read more

pharma.be meets Nathalie Moll
EFPIA Director General talked with pharma.be about the Innovative Medicines Initiative, the main challenges facing the... Read more

Events

28052018 ITCC-P4 International Workshop: Improving pediatric oncology drug development through...
27 September 2018 (Amsterdam, The Netherlands)

The overarching goal is to streamline and improve the development of new oncology drugs for children and adolescents... Read more

War On Cancer Europe 2018
20 November 2018 (London)

The technological revolution and the future of patient engagement - A conference organised by The Economist Read more

We published

2018: The pharmaceutical industry in figures
28 June 2018 (Publications)

The Pharmaceutical Industry: a key asset to scientific and medical progress Read more

What we are reading

Drugs companies are rising to the challenges of research into superbugs
On 04 July 2018 (Financial Times)

From Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations, Geneva,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu